Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Skin

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

SAEs · NSTI

Intravenous immunoglobulin showed no clear difference in serious adverse events (SAE) compared with placebo (low certainty).

1 finding from 1 review

Interventions for necrotizing soft tissue infections in adults 2018 · Cochrane Headline outcomes only
RR 0.73 [0.32, 1.65]
1 study · 100 participants
Low

SAEs · NSTI

It is very uncertain whether AB103 changes serious adverse events (SAE) compared with placebo (very low certainty).

1 finding from 1 review

Interventions for necrotizing soft tissue infections in adults 2018 · Cochrane Headline outcomes only
RR 1.49 [0.52, 4.27]
1 study · 43 participants
Very low